Aims: Diabetes-related foot disease is a major source of patient burden and societal costs. Investing in evidence-based international guidelines on diabetes-related foot disease is important to reduce this burden and costs, provided the guidelines are focused on outcomes important to key stakeholders and are evidence-based and properly implemented.Materials and Methods: The International Working Group on the Diabetic Foot (IWGDF) has published and updated international guidelines since 1999. The 2023 updates were made using the Grading of Recommendations Assessment Development and Evaluation evidence-to-decision framework. This concerns formulating relevant clinical questions and important outcomes, conducting systematic reviews of the lite...
The future for diabetes is grave. Now described as the global epidemic of the 21st century, the incr...
Aims This is the 2023 International Working Group on the Diabetic Foot guideline on the prevention ...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. To p...
Aims: Diabetes-related foot disease is a major source of patient burden and societal costs. Investin...
Diabetic foot disease is a source of major patient suffering and societal costs. Investing in eviden...
Diabetes-related foot disease results in a major global burden for patients and the healthcare syste...
Diabetic foot disease results in a major global burden for patients and the health care system. The ...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
Diabetic foot ulcers are the source of major suffering and very large costs for both the patient and...
The future for diabetes is grave. Now described as the global epidemic of the 21st century, the incr...
Aims This is the 2023 International Working Group on the Diabetic Foot guideline on the prevention ...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. To p...
Aims: Diabetes-related foot disease is a major source of patient burden and societal costs. Investin...
Diabetic foot disease is a source of major patient suffering and societal costs. Investing in eviden...
Diabetes-related foot disease results in a major global burden for patients and the healthcare syste...
Diabetic foot disease results in a major global burden for patients and the health care system. The ...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. Inve...
Diabetic foot ulcers are the source of major suffering and very large costs for both the patient and...
The future for diabetes is grave. Now described as the global epidemic of the 21st century, the incr...
Aims This is the 2023 International Working Group on the Diabetic Foot guideline on the prevention ...
Foot problems complicating diabetes are a source of major patient suffering and societal costs. To p...